Silverleafe Capital Partners’s Clover Health Investments CLOV Stock Holding History

Silverleafe Capital Partners’s Portfolio CLOV Stock Details CLOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$172K	Hold	40,000	–	–	0.05%	99
2026 Q2	$210K	Hold	40,000	–	–	0.06%	98
2026 Q1	$70.4K	Hold	40,000	–	–	0.02%	103
2025 Q4	$94K	Sell	40,000 -5,000	-11%	-$13.7K	0.03%	98
2025 Q3	$138K	Hold	45,000	–	–	0.04%	92
2025 Q2	$126K	Hold	45,000	–	–	0.04%	87
2025 Q1	$162K	Hold	45,000	–	–	0.06%	86
2024 Q4	$142K	Buy	45,000 +29,091	+183%	+$104K	0.05%	99
2024 Q3	$44.9K	Buy	+15,909	New	+$36.4K	0.02%	80

Other funds holding CLOV

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

IMC Chicago Chicago, Illinois $483B AUM 41.26% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Kestra Private Wealth Services Austin, Texas $9.37B AUM 22.72% 1-Year Est. Return

OP Asset Management Helsinki $11.8B AUM 34.59% 1-Year Est. Return

Silverleafe Capital Partners's CLOV Position: Q3 2026 in Review

Silverleafe Capital Partners held its Clover Health Investments (CLOV) position steady in Q3 2026 at 40,000 shares worth $172K. The position accounts for 0.05% of the portfolio, ranked #99.

Silverleafe Capital Partners first reported a position in CLOV in Q3 2024 and has held it in 9 quarters since. The position peaked at $210K in Q2 2026. 100 funds tracked by Wall St. Rank hold CLOV as of Q3 2026.

Silverleafe Capital Partners held 40,000 shares of Clover Health Investments worth $172K as of Q3 2026.
Silverleafe Capital Partners left its Clover Health Investments share count unchanged in Q3 2026.
Clover Health Investments made up 0.05% of Silverleafe Capital Partners's portfolio in Q3 2026, its #99 holding.
Silverleafe Capital Partners first reported a position in Clover Health Investments in Q3 2024 and has held it in 9 quarters since.
Silverleafe Capital Partners's Clover Health Investments position peaked at $210K in Q2 2026.
100 funds tracked by Wall St. Rank held Clover Health Investments as of Q3 2026.

Based on Silverleafe Capital Partners's 13F filing for Q3 2026, filed 2 Oct 2026.